Elliott Investment Management Boosts Stake in Align Technology
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 19 2026
0mins
Source: Yahoo Finance
Align Technology's stock has risen 5.02% and reached a 5-day high, reflecting positive investor sentiment.
Elliott Investment Management has become one of Align Technology's largest investors, indicating a strategic intent to push for stock price improvement and potentially engage with management to explore options for enhancing share value. Analysts have noted that Align's stock has plummeted 75% since its record high in September 2021; however, shares jumped 4% in premarket trading following news of Elliott's investment, reflecting a market reassessment of its future potential. Additionally, Barclays upgraded Align Technology to Overweight, citing strong Q4 results and an attractive valuation, which further supports the positive outlook.
The engagement from Elliott Investment Management and the upgrade from Barclays suggest a renewed confidence in Align Technology's growth potential, particularly as the company aims for a revenue growth target of 3%-4% for 2026, driven by digital innovation and DSO momentum.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALGN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALGN
Wall Street analysts forecast ALGN stock price to rise
13 Analyst Rating
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 173.530
Low
169.00
Averages
198.70
High
220.00
Current: 173.530
Low
169.00
Averages
198.70
High
220.00
About ALGN
Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Align Technology Announces Board Leadership Transition
- Board Leadership Change: Align Technology has announced a formal transition of its board leadership effective July 1, 2026, with longtime Chairman C. Raymond Larkin, Jr. retiring after over 20 years of service, succeeded by independent director Kevin Conroy, ensuring a seamless leadership handover.
- Continued Involvement: Although Larkin will retire, he will remain on the board and serve on the Nominating and Governance Committee until December 31, 2026, highlighting the company's commitment to stable governance during the transition.
- New Chairman's Background: Incoming Chairman Kevin Conroy has served as an independent director since December 2023 and has chaired the board's Compensation and Human Capital Committee since January 2026, indicating his extensive experience in corporate governance.
- Financial Performance: Align Technology forecasts Q2 revenue between $1.04 billion and $1.06 billion while reaffirming a revenue growth target of 3%-4% for 2026, with a non-GAAP EPS of $2.58, exceeding expectations by $0.29, reflecting the company's robust financial performance.
See More
Align Technology Announces Chairman Retirement and Successor
- Chairman Retirement: Align Technology announced that C. Raymond Larkin, Jr. will retire on July 1, 2026, after over 20 years of service on the Board, during which he provided strategic guidance that ensured Align's leadership in digital dentistry through various growth phases.
- New Chairman Appointment: Kevin Conroy will succeed Larkin as Chairman, having served as an independent director since December 2023 and Chair of the Compensation and Human Capital Committee since January 2026, expected to leverage his extensive experience in healthcare and technology to drive Align's innovation and growth.
- Leadership Transition Impact: Under Larkin's leadership, Align treated approximately 22.8 million patients, and Conroy's succession is seen as pivotal for Align to continue expanding its digital orthodontics market and enhancing shareholder value, especially amid increasing competition in the medical device sector.
- Future Development Outlook: Conroy expressed his commitment to closely collaborate with the management team to promote innovation and broaden access to digital orthodontics, which is anticipated to create long-term value for shareholders and further solidify Align's position in the global market.
See More
Market Capitalization Comparison: Align Technology vs. UDR
- Market Cap Comparison: Align Technology's market capitalization stands at $12.43 billion, compared to UDR's $12.23 billion, indicating Align's relative strength in the market, which may attract more interest from large funds.
- Investor Misconceptions: Many novice investors often compare stocks solely based on share price, overlooking the significance of market capitalization, which can lead to misguided investment decisions, highlighting the need for investor education.
- Market Positioning Impact: The market cap difference between Align and UDR results in distinct positioning within investment portfolios, with Align likely favored by large-cap funds while UDR may attract mid-cap fund attention, affecting liquidity and market performance.
- Stock Performance: At Thursday's close, Align's stock rose approximately 4.9%, while UDR dipped 0.1%, reflecting positive market sentiment towards Align, which could further drive its market cap growth.
See More
Resmed's Acquisition Fuels Growth in Residential Care Software Segment
- Acquisition-Driven Growth: Resmed's strategic acquisitions, including MEDIFOX DAN, have successfully expanded its Residential Care Software segment, which is expected to continue supporting growth in the coming quarters and enhance synergies within its Sleep and Breathing Health franchise.
- Mask Innovation and Resupply: In Q3 of fiscal 2026, Resmed's mask and other sales increased by 14%, driven by new product designs and resupply strategies, which not only improved patient comfort but also supported customer retention in long-term therapy.
- Enhanced Financial Flexibility: As of Q3 fiscal 2026, Resmed reported $1.66 billion in cash, with short-term debt at $260 million and long-term debt at $404 million, resulting in a debt-to-capital ratio improvement to 5.9%, indicating relatively low financial risk.
- Macroeconomic Challenges: Despite Resmed's solid financial performance, it faces challenges from macroeconomic pressures and intense competition, which could impact demand and operating costs, potentially leading to negative effects on the company's overall performance.
See More
Align Expands Manufacturing Base in Hyderabad, India
- Significant Investment: Align plans to establish a new manufacturing facility in Hyderabad, India, by 2027, with an investment of approximately $200 million expected to create over 300 direct jobs, reflecting the company's commitment to the Asia-Pacific market.
- Strategic Optimization: The new facility will enhance Align's operational capabilities in high-growth markets, improve supply chain resilience and operational efficiency, thereby driving shareholder value and solidifying its competitive position in the global market.
- Talent and Technology Synergy: Hyderabad's strong talent base and innovation ecosystem provide an ideal environment for Align's expansion, supporting ongoing innovation and development in digital orthodontics and restorative dentistry.
- Global Network Expansion: This investment marks Align's first manufacturing presence in India, complementing its existing Global Capability Center and Innovation Center in Hyderabad, further reinforcing the region's strategic importance within Align's global operations network.
See More
Align Technology Plans $200 Million Stock Buyback
- Buyback Program Initiation: Align Technology has announced a plan to repurchase $200 million of its common stock through open market transactions, reflecting management and the Board's confidence in the company's long-term strategy and growth opportunities, which is expected to enhance shareholder value.
- Clear Funding Source: The buyback will be executed under Align's existing $1 billion stock repurchase program, with approximately $1.06 billion in cash and cash equivalents as of March 31, 2026, ensuring ample funding for the repurchase.
- Market Condition Assessment: The timing and number of shares repurchased will be evaluated based on market conditions, stock price, and trading volume, demonstrating the company's flexibility and prudence in executing the buyback.
- Long-Term Strategic Execution: Align emphasizes its commitment to focusing on strategic priorities, delivering meaningful outcomes for doctors and patients, and creating long-term shareholder value through sustainable growth and performance, showcasing its leadership in the digital dentistry space.
See More
Align Technology Announces Board Leadership Transition
- Board Leadership Change: Align Technology has announced a formal transition of its board leadership effective July 1, 2026, with longtime Chairman C. Raymond Larkin, Jr. retiring after over 20 years of service, succeeded by independent director Kevin Conroy, ensuring a seamless leadership handover.
- Continued Involvement: Although Larkin will retire, he will remain on the board and serve on the Nominating and Governance Committee until December 31, 2026, highlighting the company's commitment to stable governance during the transition.
- New Chairman's Background: Incoming Chairman Kevin Conroy has served as an independent director since December 2023 and has chaired the board's Compensation and Human Capital Committee since January 2026, indicating his extensive experience in corporate governance.
- Financial Performance: Align Technology forecasts Q2 revenue between $1.04 billion and $1.06 billion while reaffirming a revenue growth target of 3%-4% for 2026, with a non-GAAP EPS of $2.58, exceeding expectations by $0.29, reflecting the company's robust financial performance.
See More
Align Technology Announces Chairman Retirement and Successor
- Chairman Retirement: Align Technology announced that C. Raymond Larkin, Jr. will retire on July 1, 2026, after over 20 years of service on the Board, during which he provided strategic guidance that ensured Align's leadership in digital dentistry through various growth phases.
- New Chairman Appointment: Kevin Conroy will succeed Larkin as Chairman, having served as an independent director since December 2023 and Chair of the Compensation and Human Capital Committee since January 2026, expected to leverage his extensive experience in healthcare and technology to drive Align's innovation and growth.
- Leadership Transition Impact: Under Larkin's leadership, Align treated approximately 22.8 million patients, and Conroy's succession is seen as pivotal for Align to continue expanding its digital orthodontics market and enhancing shareholder value, especially amid increasing competition in the medical device sector.
- Future Development Outlook: Conroy expressed his commitment to closely collaborate with the management team to promote innovation and broaden access to digital orthodontics, which is anticipated to create long-term value for shareholders and further solidify Align's position in the global market.
See More
Market Capitalization Comparison: Align Technology vs. UDR
- Market Cap Comparison: Align Technology's market capitalization stands at $12.43 billion, compared to UDR's $12.23 billion, indicating Align's relative strength in the market, which may attract more interest from large funds.
- Investor Misconceptions: Many novice investors often compare stocks solely based on share price, overlooking the significance of market capitalization, which can lead to misguided investment decisions, highlighting the need for investor education.
- Market Positioning Impact: The market cap difference between Align and UDR results in distinct positioning within investment portfolios, with Align likely favored by large-cap funds while UDR may attract mid-cap fund attention, affecting liquidity and market performance.
- Stock Performance: At Thursday's close, Align's stock rose approximately 4.9%, while UDR dipped 0.1%, reflecting positive market sentiment towards Align, which could further drive its market cap growth.
See More
Resmed's Acquisition Fuels Growth in Residential Care Software Segment
- Acquisition-Driven Growth: Resmed's strategic acquisitions, including MEDIFOX DAN, have successfully expanded its Residential Care Software segment, which is expected to continue supporting growth in the coming quarters and enhance synergies within its Sleep and Breathing Health franchise.
- Mask Innovation and Resupply: In Q3 of fiscal 2026, Resmed's mask and other sales increased by 14%, driven by new product designs and resupply strategies, which not only improved patient comfort but also supported customer retention in long-term therapy.
- Enhanced Financial Flexibility: As of Q3 fiscal 2026, Resmed reported $1.66 billion in cash, with short-term debt at $260 million and long-term debt at $404 million, resulting in a debt-to-capital ratio improvement to 5.9%, indicating relatively low financial risk.
- Macroeconomic Challenges: Despite Resmed's solid financial performance, it faces challenges from macroeconomic pressures and intense competition, which could impact demand and operating costs, potentially leading to negative effects on the company's overall performance.
See More
Align Expands Manufacturing Base in Hyderabad, India
- Significant Investment: Align plans to establish a new manufacturing facility in Hyderabad, India, by 2027, with an investment of approximately $200 million expected to create over 300 direct jobs, reflecting the company's commitment to the Asia-Pacific market.
- Strategic Optimization: The new facility will enhance Align's operational capabilities in high-growth markets, improve supply chain resilience and operational efficiency, thereby driving shareholder value and solidifying its competitive position in the global market.
- Talent and Technology Synergy: Hyderabad's strong talent base and innovation ecosystem provide an ideal environment for Align's expansion, supporting ongoing innovation and development in digital orthodontics and restorative dentistry.
- Global Network Expansion: This investment marks Align's first manufacturing presence in India, complementing its existing Global Capability Center and Innovation Center in Hyderabad, further reinforcing the region's strategic importance within Align's global operations network.
See More
Align Technology Plans $200 Million Stock Buyback
- Buyback Program Initiation: Align Technology has announced a plan to repurchase $200 million of its common stock through open market transactions, reflecting management and the Board's confidence in the company's long-term strategy and growth opportunities, which is expected to enhance shareholder value.
- Clear Funding Source: The buyback will be executed under Align's existing $1 billion stock repurchase program, with approximately $1.06 billion in cash and cash equivalents as of March 31, 2026, ensuring ample funding for the repurchase.
- Market Condition Assessment: The timing and number of shares repurchased will be evaluated based on market conditions, stock price, and trading volume, demonstrating the company's flexibility and prudence in executing the buyback.
- Long-Term Strategic Execution: Align emphasizes its commitment to focusing on strategic priorities, delivering meaningful outcomes for doctors and patients, and creating long-term shareholder value through sustainable growth and performance, showcasing its leadership in the digital dentistry space.
See More
